Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner

被引：82

作者：

Tanaka T. ^{[1
]}

Nabatame H. ^{[1
]}

Tanifuji Y. ^{[1
]}

机构：

[1] Department of Anesthesiology, The Jikei University, School of Medicine, Minato-ku, Tokyo 105-8461

来源：

Journal of Anesthesia | 2005年 / 19卷 / 4期

关键词：

Intravenous glucose tolerance test; Isoflurane; Sevoflurane;

D O I：

10.1007/s00540-005-0341-1

中图分类号：

学科分类号：

摘要：

Purpose: The dose-dependent effects of sevoflurane and isoflurane anesthesia on glucose tolerance were compared in humans. Methods: A prospective, randomized clinical study was conducted in 30 patients. The 30 patients were divided randomly into three sevoflurane anesthesia groups (0.5, 1.0, and 1.5 minimum alveolar concentration [MAC]) and three isoflurane anesthesia groups (0.5, 1.0, and 1.5 MAC). Induction of anesthesia was accomplished by inhalation of the volatile agent and nitrous oxide. After induction, anesthesia was maintained at the designated MAC for 15min without surgical stimulation. The intravenous glucose tolerance test (IVGTT) was performed in these 30 patients while they were under general anesthesia and again several days after surgery in 5 of these patients while they were awake, as a control. Results: The insulinogenic index (change in concentration of immunoreactive insulin/change in glucose concentration), the acute insulin response, and rates of glucose disappearance were significantly lower in all anesthesia groups than in the control group. However, the insulinogenic index, acute insulin response, and the glucose disappearance rate did not differ significantly among the six anesthesia groups. Conclusion: Sevoflurane anesthesia impairs glucose tolerance to the same degree as does isoflurane anesthesia. Glucose intolerance during sevoflurane or isoflurane anesthesia is independent of agent and dosage up to 1.5 MAC. © JSA 2005.

引用

页码：277 / 281

页数：4

共 14 条

[1]

Camu F., Carbohydrate intolerance during halothane anesthesia in dogs, Acta Anaesthesiol. Belg., 24, pp. 177-188, (1973)

[2]

Camu F., Impaired early insulin response to glycemic stimulus during enflurane anesthesia in dogs, Acta Anaesthesiol. Belg., 27, (1976)

[3]

Diltoer M., Camu F., Glucose homeostasis and insulin secretion during isoflurane anesthesia in humans, Anesthesiology, 68, pp. 880-886, (1988)

[4]

Saho S., Kadota Y., Sameshima T., Miyao J., Tsurumaru T., Yoshimura N., The effects of sevoflurane anesthesia on insulin secretion and glucose metabolism in pigs, Anesth. Analg., 84, pp. 1359-1365, (1997)

[5]

Iwasaka H., Itoh K., Miyakawa H., Kitano T., Taniguchi K., Honda N., Glucose intolerance during prolonged sevoflurane anaesthesia, Can. J. Anaesth., 43, pp. 1059-1061, (1996)

[6]

Desborough J.P., Knowles M.G., Hall G.M., Effects of isoflurane-nitrous oxide anesthesia on insulin secretion in female patients, Br. J. Anaesth., 80, pp. 250-252, (1998)

[7]

Pfeifer M.A., Halter J.B., Porte Jr. D., Insulin secretion in diabetes mellitus, Am. J. Med., 70, pp. 579-588, (1981)

[8]

Desborough J.P., Jones P.M., Persaud S.J., Landon M.J., Howell S.L., Isoflurane inhibits insulin secretion from isolated rat pancreatic islets of Langerhans, Br. J. Anaesth., 71, pp. 873-876, (1993)

[9]

Gingerich R., Wright P.H., Paradise R.R., Inhibition by halothane of glucose stimulated insulin secretion in isolated pieces of rat pancreas, Anesthesiology, 40, pp. 449-452, (1974)

[10]

Staub H., Untersuchungen über den Zuckerstoffwechsel des Menschen, Z. Klin. Med., 91, pp. 44-60, (1921)

← 1 2 →